News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,344 Results
Type
Article (48939)
Company Profile (196)
Press Release (568209)
Section
Business (171189)
Career Advice (3029)
Deals (31300)
Drug Delivery (104)
Drug Development (78231)
Employer Resources (170)
FDA (14895)
Job Trends (14160)
News (301919)
Policy (29919)
Tag
Academia (2757)
Alliances (43859)
Alzheimer's disease (1366)
Approvals (14857)
Artificial intelligence (198)
Bankruptcy (267)
Best Places to Work (11526)
Biotechnology (151)
Breast cancer (224)
Cancer (1680)
Cardiovascular disease (130)
Career advice (2544)
CAR-T (127)
Cell therapy (339)
Clinical research (62497)
Collaboration (633)
Compensation (281)
COVID-19 (2690)
C-suite (136)
Data (1516)
Diabetes (203)
Diagnostics (6355)
Earnings (69381)
Employer resources (150)
Events (95453)
Executive appointments (469)
FDA (15698)
Funding (542)
Gene therapy (241)
GLP-1 (689)
Government (4542)
Healthcare (18517)
Infectious disease (2794)
Inflammatory bowel disease (124)
Interviews (543)
IPO (15627)
Job creations (3092)
Job search strategy (2105)
Layoffs (438)
Legal (6437)
Lung cancer (252)
Manufacturing (220)
Medical device (12562)
Medtech (12566)
Mergers & acquisitions (16029)
Metabolic disorders (543)
Neuroscience (1767)
NextGen: Class of 2025 (6419)
Non-profit (4490)
Northern California (1844)
Obesity (299)
Opinion (249)
Patents (140)
People (46154)
Phase I (19543)
Phase II (27521)
Phase III (20833)
Pipeline (647)
Postmarket research (2364)
Preclinical (8243)
Radiopharmaceuticals (259)
Rare diseases (324)
Real estate (5187)
Regulatory (20605)
Research institute (2483)
Resumes & cover letters (523)
Southern California (1634)
Startups (3165)
United States (16501)
Vaccines (641)
Weight loss (219)
Date
Today (140)
Last 7 days (599)
Last 30 days (2708)
Last 365 days (34027)
2025 (2833)
2024 (34611)
2023 (39657)
2022 (50210)
2021 (54644)
2020 (52980)
2019 (46028)
2018 (34840)
2017 (30813)
2016 (29761)
2015 (34054)
2014 (25962)
2013 (21379)
2012 (22672)
2011 (23283)
2010 (20820)
Location
Africa (853)
Arizona (154)
Asia (36742)
Australia (6318)
California (4247)
Canada (1537)
China (372)
Colorado (193)
Connecticut (205)
Europe (83948)
Florida (606)
Georgia (156)
Illinois (403)
Indiana (222)
Maryland (670)
Massachusetts (3287)
Michigan (173)
Minnesota (300)
New Jersey (1204)
New York (1206)
North Carolina (804)
Northern California (1844)
Ohio (149)
Pennsylvania (963)
South America (1180)
Southern California (1634)
Texas (598)
Utah (125)
Washington State (426)
617,344 Results for "on target laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
On Target Laboratories Appoints Bill Peters as CEO
December 11, 2024
·
3 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Neuroscience
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
January 30, 2025
·
7 min read
Press Releases
Rancho Biosciences and ONTOFORCE Collaborate to Leverage High Quality Data for Target Identification
January 15, 2025
·
3 min read
BioMidwest
On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board
On Target Laboratories, Inc. announced the appointment of Scott Huennekens as Executive Chairperson of the Board.
January 3, 2024
·
2 min read
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
January 23, 2025
·
13 min read
Press Releases
FORE Biotherapeutics Highlights Recent Pipeline Achievements for its Targeted-Oncology Program and Provides Strategic Objectives for 2025
January 9, 2025
·
6 min read
Press Releases
NeuroPace Issues 2025 Financial Guidance Targets
January 29, 2025
·
4 min read
1 of 61,735
Next
